Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Savara to Present at the Jefferies London Healthcare Conference


Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the Jefferies London Healthcare Conference being held November 16-19, 2021.

A pre-recorded, on-demand webcast of Savara's presentation will be available on the conference website beginning Thursday, November 18 at 3:00 am ET through Friday, November 19 at 12:00 pm ET. Additionally, a replay of the presentation will be available on the Investors page of Savara's website at www.savarapharma.com/investors/events-presentations/ for 90 days following the event.

About Savara

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.

More information can be found at www.savarapharma.com. (Twitter: @SavaraPharma, LinkedIn: www.linkedin.com/company/savara-pharmaceuticals/).


These press releases may also interest you

at 10:50
Integrated Biosciences Partners with Project 8p Foundation to Pioneer a New Path to Groundbreaking Treatments for Chromosomal Disorders
Integrated Biosciences, a biotechnology company pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases, today announced a strategic partnership with the patient-led Project 8p...

at 10:45
Orchard Software Announces New Billing Functionality to Improve Reimbursements
Today, Orchard Software announced the release of its expanded billing functionality to include insurance verification automation. With this addition, Orchard's enterprise laboratory information system (LIS) solutions can decrease denial rates that...

at 10:44
BAE Systems breaks ground on cutting-edge engineering and product development site in Maple Grove
BAE Systems' Combat Mission Systems (CMS) business is marking the start of construction on its new 236,000-square-foot facility in Maple Grove, Minnesota. Designed with functionality and a future-proofed blueprint, the site will provide the...

at 10:39
nShift: Delivery experience key to Black-Friday success
The speed and convenience of the delivery is more important to Black Friday shoppers than deals and discounts, according to research.  Retailers must give customers the delivery experience they want at the same...

at 10:38
OPTISHOT GOLF UNVEILS NOVA: THE ULTIMATE MADE-IN-AMERICA GOLF SIMULATOR
OptiShot Golf, the leading innovator in golf simulation technology, proudly announced the launch of Nova, the pinnacle of golf simulation innovation. Designed and manufactured entirely in America, Nova redefines the golfing experience with its...

at 10:36
Tata Elxsi delivers 13% revenue growth in FY24; EBITDA margin at 29.5%
Tata Elxsi (BSE: 500408 | NSE: TATAELXSI), amongst the world's leading providers of design led technology services, announced its fourth quarter results for the period ending 31st March 2024. Highlights of the Year Ended 31st March 2024 Revenues...

More news about Science and technology...


News published on and distributed by: